{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:02:14Z","timestamp":1781607734436,"version":"3.54.5"},"reference-count":16,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2022,5,3]]},"DOI":"10.1080\/14656566.2022.2060078","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T13:02:38Z","timestamp":1649163758000},"page":"769-773","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Are there advantages of daprodustat over erythropoiesis-stimulating agents (ESAs) in treating anemia associated with chronic kidney disease (CKD)?"],"prefix":"10.1080","volume":"23","author":[{"given":"Sheila A","family":"Doggrell","sequence":"first","affiliation":[{"name":"Biomedical Communications, wynnum, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"cit0001","author":"Singh AK","year":"2021","journal-title":"N Engl J Med"},{"key":"cit0002","author":"Singh AK","year":"2021","journal-title":"N Engl J Med"},{"key":"cit0003","unstructured":"NIH National institute of diabetes and digestive and kidney disease. Anaemia in chronic kidney disease. [cited 2021 Dec 21]. Available from: https:\/\/www.niddk.nih.gov\/health-information\/kidney-disease\/anemia"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011111078"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015091009"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfy014"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfy013"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.658079"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01903-7"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035938"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2025956"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab065"},{"key":"cit0013","unstructured":"ClinicalTrials.gov. Post-marketing surveillance of EVRENZO Tablets (Roxadustat) in patients with renal anemia. [cited 2022 Mar 21]. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04408820?term=roxadustat&draw=2&rank=3"},{"issue":"1","key":"cit0014","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/13.1.10","volume":"36","author":"Schneider J","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2020.1747436"},{"key":"cit0016","unstructured":"Liu AA. FibroGen hope to keep their roxadustat dream alive with new FDA meeting. Fierce Pharma https:\/\/www.fiercepharma.com\/marketing\/astrazeneca-fibrogen-keep-roxadustat-s-anemia-dream-alive-new-fda-meeting [cited 2022 Jan 4]."}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2022.2060078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T10:07:59Z","timestamp":1652954879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2022.2060078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,5,3]]}},"alternative-id":["10.1080\/14656566.2022.2060078"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2022.2060078","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}